Stay updated on ATHENA Clinical Trial: Rucaparib+Nivolumab in Ovarian Cancer

Sign up to get notified when there's something new on the ATHENA Clinical Trial: Rucaparib+Nivolumab in Ovarian Cancer page.
Latest website image capture
Clouds background image

Latest updates to the ATHENA Clinical Trial: Rucaparib+Nivolumab in Ovarian Cancer page

  1. Check
    5 days ago
    No Change Detected
  2. Check
    12 days ago
    Change Detected
    Summary
    No significant additions or deletions were detected. The page content appears unchanged.
    Difference
    0.1%
    Check dated 2025-11-01T23:55:56.000Z thumbnail image
  3. Check
    19 days ago
    No Change Detected
  4. Check
    41 days ago
    Change Detected
    Summary
    The page now displays a funding-related operating-status notice and a new software/document version (v3.2.0), replacing the previous v3.1.0.
    Difference
    2%
    Check dated 2025-10-04T03:16:39.000Z thumbnail image
  5. Check
    48 days ago
    Change Detected
    Summary
    Added a new version label (v3.1.0) and removed several drug-safety/quality topics and an older version label (v3.0.2). Overall, this signals a version update with a cleanup of older safety-topic content.
    Difference
    0.2%
    Check dated 2025-09-27T02:13:37.000Z thumbnail image
  6. Check
    62 days ago
    Change Detected
    Summary
    Version updated from v3.0.1 to v3.0.2; the 'Back to Top' link was removed.
    Difference
    0.1%
    Check dated 2025-09-12T17:19:21.000Z thumbnail image
  7. Check
    69 days ago
    Change Detected
    Summary
    The web page has been updated from version 3.0.0 to version 3.0.1, indicating a revision in the content. There are no significant changes to core content, names, pricing, or availability.
    Difference
    0.1%
    Check dated 2025-09-05T13:57:51.000Z thumbnail image
  8. Check
    76 days ago
    Change Detected
    Summary
    The webpage has undergone significant updates, including the addition of new facility names and locations, as well as the introduction of various medical topics and resources related to cancer treatment. Notably, the previous version's references to certain genetic resources and specific locations have been removed.
    Difference
    19%
    Check dated 2025-08-29T08:36:37.000Z thumbnail image

Stay in the know with updates to ATHENA Clinical Trial: Rucaparib+Nivolumab in Ovarian Cancer

Enter your email address, and we'll notify you when there's something new on the ATHENA Clinical Trial: Rucaparib+Nivolumab in Ovarian Cancer page.